The effects of oral nutritional supplement (ONS) during chemoradiotherapy in patients with pancreatic and/or esophageal cancer
Not Applicable
Recruiting
- Conditions
- Patients with pancreatic and/or esophageal cancer, who are scheduled to receive chemoradiotherapy
- Registration Number
- JPRN-UMIN000006274
- Lead Sponsor
- Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Medical Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients on TPN [total parenteral nutrition] 2.Patients with milk protein allergy 3.Patients with Dysphagia 4.Patients who are judged inappropriate for the entry into the study by the investigater
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method